Time | Subject | Room |
---|---|---|
7.00-8.30 | Registration Open | |
8.15-8.30 | Opening Ceremony | |
Program supported by Thailand Hub of Talents in Cancer Immunotherapy, (TTCI) |
||
8.30-10.00 |
Plenary Session 1: Cellular Immunotherapy I
• Role of HSCT vs CAR T cells in Hematologic Malignancy
• Challenges in delivering cellular therapies for transplant recipients and cancer
patients
• mRNA-based T cell engineering for treatment of virus-related cancer and virus
infection |
|
10.00-10.30 | Coffee Break | |
10.30-12.00 |
Plenary Session 2: Cellular Immunotherapy II
• Clinical Application of Mesenchymal Stem Cells: Current Trends and Future
Directions
• T cell receptors and MHC diversity in risk, prognosis, and therapy for gliomas
• Novel pans solid tumor CAR T cells and first in human trial in DIPG |
|
12.00-13.00 | Lunch | |
13.00-13.30 | Sponsor Session I | |
13.30-14.00 | Sponsor Session II | |
14.00-14.30 | Short Oral Session | |
14.30-16.30 | Coffee Break with Poster Session | |
14.00-16.30 | Concurrent Workshop (Major Sponsor) | 1201 |
18.00-21.00 |
Welcome Reception (Mandarin Hotel, Manage by Center Point) |
Time | Subject | Room |
---|---|---|
8.30-10.00 |
Plenary Session 3: Haematopoietic Stem Cell Transplantation
• HSCT: An update
• Saving Lives Across Borders: The Asia-Pacific Unrelated Stem Cell Donor Registry
Experience |
|
10.00-10.30 | Coffee Break | |
10.30-12.00 |
Plenary Session 4: HLA Genomics and Clinical Relevance
• HLA in Diseases Susceptibility and Personalized Medicine
• Clinical implementation of HLA long-read sequencing
• HLA Typing and Beyond with Nanopore Sequencing
• Beyond Traditional HLA Typing: NGS and HLA Imputation for Comprehensive Analysis of
HLA Alleles in Thai SLE Patients |
|
12.00-13.00 | Lunch | |
13.00-13.30 |
Sponsor Session III (Thermo Fisher)
• Improving The Efficiency And Reliability Of Post-Transplantation Monitoring And Prognosis
with Donor-Derived Cell-Free DNA (dd-cfDNA) |
|
13.30-14.00 |
Sponsor Session IV (TBG)
• HLA typing using Nanopore with Automation |
|
14.00-14.30 | Short Oral Session | |
14.30-16.30 | Coffee Break with Poster Session | |
14.00-16.30 | Concurrent Workshop (Major Sponsor) | 1201 |
18.00-21.00 | Gala Dinner (Councilor and Speaker Plus Guest with ticket) |
Time | Subject | Room |
---|---|---|
8.30-10.00 |
Plenary Session 5: Solid Organ Transplantation I
• Implementation of Virtual Crossmatching in Australia: the laboratory experience
• Determining compatibility in Solid Organ Transplantation – Challenges and
Opportunities
• Non-HLA antibodies in solid organ transplant |
|
10.00-10.30 | Coffee Break | |
10.30-12.00 |
Interactive Session
• Case Studies for Complex Patients |
|
12.00-13.00 | Lunch | |
13.00-13.30 |
Special Lecture by the ASHI President
• Expanding Access to Transplantation: Utilization of A2 Kidneys for O and B Recipients |
|
13.30-14.30 | Short Oral and Poster Session | |
14.30-15.00 | Coffee Break | |
15.00-16.00 |
Plenary Session 6: Solid Organ Transplantation II
• Management of Highly sensitized kidney transplant recipients |
|
16.00-16.15 | Concluding Remark and Closing |